MKI67 and neoplasm: Consistent with the anti-tumor effect, GDC-0810 treated tumors display reduced Ki-67 staining (Figure 5B and Figure 5—figure supplement 2) and altered ER target gene transcription in a manner consistent with ER antagonism (Figure 5C).